drugset / Trial / NCT01091220
Evaluation of the Effects of Certolizumab Pegol on Semen Quality in Healthy Male Volunteers
RandomizedParallel-groupDouble-blind
Summary
The primary objective of this study is to evaluate the effect of certolizumab pegol (CZP) on the quality of sperm obtained from healthy male volunteers.
Timeline
- Start
- 2010-03
- Primary completion
- 2011-03
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Certolizumab Pegol | Protein / enzyme biologic | 400 mg | Subcutaneous |